Stanford Medicine's Zakia Rahman discusses skin cancer prevention and tips to have healthy skin in this Ask Me Anything.
New CDC recommendation for universal hepatitis B screening could significantly reduce liver cancer in Asians and Black people, researchers say.
Stanford Medicine researchers take a unique approach to refine engineered immune cells meant to kill cancer.
Researchers at Stanford Medicine investigate cancer disparities in LGBTQ populations and how to address them.
Over the last six decades in the U.S., gastric, or stomach, cancer rates have plummeted. But around the world, gastric cancer remains a leading cause …
As the year comes to a close, we're sharing the most-read stories, most-viewed videos and most popular stories on social media of 2022.
Stanford physician Samuel LeBaron discusses his book, which covers death and how to prepare for and receive end-of-life care.
As FDA weighs a ban on menthol in cigarettes, study shows how the tobacco industry targeted products to women, teens and Black people.
Brain tumors are among the most deadly and difficult-to-treat cancers. Glioblastoma, a particularly aggressive form, kills more than 10,000 Americans a year and has a …
Researchers from Stanford have developed a wearable sensor to monitor the size of tumors, which could assist new cancer drug evaluations.
Researchers have created a menstrual pad that can passively help detect HPV, potentially offering a screening method other than pap smears.
We explore the most basic molecular elements of human biology in the lead story for the latests issue of Stanford Medicine magazine.
Research into the destructive influence tiny DNA circles have on cancer presents endless ideas for clearly describing groundbreaking science.
A group of Black women work toward a peer navigation program to help other Black women survive breast cancer.
Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.
Researchers are using data science to home in on therapies that will work best for specific patients, advancing precision oncology.
